Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
9.00
+0.07 (0.78%)
At close: Nov 20, 2024, 4:00 PM
9.06
+0.06 (0.67%)
Pre-market: Nov 21, 2024, 7:27 AM EST
Teladoc Health Revenue
Teladoc Health had revenue of $640.51M in the quarter ending September 30, 2024, a decrease of -2.99%. This brings the company's revenue in the last twelve months to $2.59B, up 0.39% year-over-year. In the year 2023, Teladoc Health had annual revenue of $2.60B with 8.13% growth.
Revenue (ttm)
$2.59B
Revenue Growth
+0.39%
P/S Ratio
0.59
Revenue / Employee
$462,430
Employees
5,600
Market Cap
1.55B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
Dec 31, 2019 | 553.31M | 135.40M | 32.40% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Clover Health Investments | 2.12B |
10x Genomics | 629.74M |
Kiniksa Pharmaceuticals International, | 384.10M |
Certara | 372.80M |
Immunocore Holdings | 296.31M |
Dynavax Technologies | 260.81M |
Arvinas | 161.10M |
Nurix Therapeutics | 56.42M |
TDOC News
- 13 days ago - Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303A.08 - GlobeNewsWire
- 21 days ago - Teladoc Health, Inc. (TDOC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Teladoc Health Reports Third Quarter 2024 Results - GlobeNewsWire
- 4 weeks ago - Teladoc Health Needs A Turnaround Plan - Seeking Alpha
- 5 weeks ago - Teladoc Health to Announce Third Quarter 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewsWire
- 2 months ago - U.S. Direct To Consumer Telehealth Services Market Trends Analysis Report 2024-2030 Featuring Key Players - American Well, Teladoc, HealthTap, and MeMD - GlobeNewsWire
- 2 months ago - Teladoc rises on increased demand, should you buy this high risk play? - Invezz